JP2005518354A5 - - Google Patents

Download PDF

Info

Publication number
JP2005518354A5
JP2005518354A5 JP2003545335A JP2003545335A JP2005518354A5 JP 2005518354 A5 JP2005518354 A5 JP 2005518354A5 JP 2003545335 A JP2003545335 A JP 2003545335A JP 2003545335 A JP2003545335 A JP 2003545335A JP 2005518354 A5 JP2005518354 A5 JP 2005518354A5
Authority
JP
Japan
Prior art keywords
component
agents
pharmaceutical composition
codrug
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2003545335A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005518354A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/037035 external-priority patent/WO2003043657A1/en
Publication of JP2005518354A publication Critical patent/JP2005518354A/ja
Publication of JP2005518354A5 publication Critical patent/JP2005518354A5/ja
Abandoned legal-status Critical Current

Links

JP2003545335A 2001-11-19 2002-11-19 コドラッグを含有する医薬組成物 Abandoned JP2005518354A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33151201P 2001-11-19 2001-11-19
PCT/US2002/037035 WO2003043657A1 (en) 2001-11-19 2002-11-19 Topical delivery of codrugs

Publications (2)

Publication Number Publication Date
JP2005518354A JP2005518354A (ja) 2005-06-23
JP2005518354A5 true JP2005518354A5 (cg-RX-API-DMAC7.html) 2006-01-19

Family

ID=23294274

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003545335A Abandoned JP2005518354A (ja) 2001-11-19 2002-11-19 コドラッグを含有する医薬組成物

Country Status (6)

Country Link
US (3) US20030118528A1 (cg-RX-API-DMAC7.html)
EP (1) EP1448231A1 (cg-RX-API-DMAC7.html)
JP (1) JP2005518354A (cg-RX-API-DMAC7.html)
AU (1) AU2002350207A1 (cg-RX-API-DMAC7.html)
CA (1) CA2467559A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003043657A1 (cg-RX-API-DMAC7.html)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417227B1 (en) * 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate
BR0209198A (pt) * 2001-04-26 2004-06-08 Control Delivery Sys Inc Métodos de sìntese de compostos contendo fenol
US20040022853A1 (en) * 2001-04-26 2004-02-05 Control Delivery Systems, Inc. Polymer-based, sustained release drug delivery system
NZ529661A (en) * 2001-06-05 2006-03-31 Control Delivery Systems Sustained-release analgesic compounds
IN2014DN10834A (cg-RX-API-DMAC7.html) * 2001-09-17 2015-09-04 Psivida Inc
US20030118528A1 (en) * 2001-11-19 2003-06-26 Walters Kenneth A. Topical delivery of codrugs
EP1461122A4 (en) * 2001-12-10 2006-08-23 Control Delivery Sys Inc TREATMENT OF DISEASES OF THE UROGENITAL SYSTEM
US20040022815A1 (en) * 2002-08-05 2004-02-05 Orchid Health Care Novel pharmaceutical composition of ceftiofur
WO2005009480A2 (en) * 2003-06-11 2005-02-03 Control Delivery Systems, Inc. Implants containing codrugs
US8267914B1 (en) * 2003-10-16 2012-09-18 University Of Notre Dame Du Lac Method and apparatus for AC electrospray
US9248146B2 (en) * 2003-10-24 2016-02-02 Adhesives Research, Inc. Dissolvable adhesive films for delivery of pharmaceutical or cosmetic agents
CA2543350C (en) 2003-10-24 2011-04-26 Adhesives Research, Inc. Disintegratable films for diagnostic devices
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
WO2005110485A1 (en) * 2004-05-14 2005-11-24 Interface Biologics Inc. Polymeric coupling agents and pharmaceutically-active polymers made therefrom
WO2006047466A2 (en) * 2004-10-21 2006-05-04 Duke University Ophthamological drugs
US20060105941A1 (en) * 2004-11-12 2006-05-18 Allergan, Inc. Mixed antibiotic codrugs
US20060222692A1 (en) * 2005-03-31 2006-10-05 Fairfield Clinical Trials Llc Method and compositions for transdermal administration of antimicrobial medications
US20070254920A1 (en) * 2006-04-26 2007-11-01 Aerie Pharmaceuticals, Inc. Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
WO2008115590A1 (en) * 2007-03-21 2008-09-25 Alza Corporation Apparatus and method for transdermal delivery of a benzodiazepine
US9174042B2 (en) 2007-05-25 2015-11-03 Empi, Inc. Wound healing electrode set
AU2009249071A1 (en) 2008-05-20 2009-11-26 Neurogesx, Inc. Hepatoprotectant acetaminophen mutual prodrugs
US20110150946A1 (en) * 2008-08-22 2011-06-23 Al-Ghananeem Abeer M Transdermal Delivery of Apomorphine Using Microneedles
US20100086581A1 (en) * 2008-10-07 2010-04-08 Ernest Bove Method for purpura reduction and prevention
US11731991B2 (en) 2008-11-03 2023-08-22 Lehigh University Augmenting moieties for anti-inflammatory compounds
DE102009008256A1 (de) * 2009-02-10 2010-08-12 Lts Lohmann Therapie-Systeme Ag Prodrugs vom Typ N-hydroxylierter Amidine, Guanidine und/oder Aminohydrazone zur Applikation über die Haut
BRPI0900238A2 (pt) * 2009-02-12 2010-10-26 Arch Chem Inc composição antimicrobiana e processo para controle da contaminação microbiana em processos de fermentação alcóolica
DK2403482T3 (en) 2009-03-04 2018-03-05 Emplicure Ab ABUSE RESISTANT FORMULATION
WO2010128300A1 (en) 2009-05-08 2010-11-11 Aduro Materials Ab Composition for sustained drug delivery comprising geopolymeric binder
US9364485B2 (en) 2009-08-31 2016-06-14 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
US20160038600A1 (en) 2012-08-03 2016-02-11 Neonc Technologies Inc. Pharmaceutical compositions comprising poh derivatives
NZ608598A (en) * 2010-09-07 2015-03-27 Orexo Ab A transdermal drug administration device
ES3056006T3 (en) * 2010-12-17 2026-02-17 Univ Southern California Methods and devices for using isoperillyl alcohol
EP2630952A1 (en) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
BR112015021836A2 (pt) 2013-03-08 2017-07-18 Allergan Inc conjugados de antibióticos diretamente ligados com drogas esteroides
WO2014138359A1 (en) * 2013-03-08 2014-09-12 Allergan, Inc. Steroid antibiotic conjugates
US9512068B2 (en) 2013-03-15 2016-12-06 Rutgers, The State University Of New Jersey Augmenting moieties for anti-inflammatory compounds
WO2014195352A1 (en) 2013-06-04 2014-12-11 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
WO2016174674A1 (en) 2015-04-27 2016-11-03 The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center Egr1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
SG10201912394VA (en) 2015-07-15 2020-02-27 Celator Pharmaceuticals Inc Improved nanoparticle delivery systems
US10286095B2 (en) 2015-09-11 2019-05-14 Olson Ip Technologies, Inc. Travel kit
KR20180058758A (ko) 2015-09-22 2018-06-01 그레이버그 비젼, 인크. 안구 장애의 치료를 위한 화합물 및 조성물
WO2017165502A1 (en) * 2016-03-22 2017-09-28 The General Hospital Corporation Compositions and methods for topical delivery of pharmaceutical agents
WO2018081389A1 (en) * 2016-10-26 2018-05-03 Georgia State University Research Foundation, Inc. Devices and methods for the treatment of a zoonotic herpesvirus infection
MX2019011242A (es) 2017-03-23 2020-01-21 Graybug Vision Inc Farmacos y composiciones para el tratamiento de trastornos oculares.
MX2019013363A (es) 2017-05-10 2020-01-13 Graybug Vision Inc Microparticulas de liberacion extendida y suspensiones de las mismas para terapia medica.
EP3740494A4 (en) 2018-02-02 2021-11-03 Ripple Therapeutics Corporation GLASS FORMULATIONS WITH STEROID DIMERS AND USES THEREOF
WO2020154815A1 (en) 2019-02-01 2020-08-06 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
JP2022548464A (ja) * 2019-07-10 2022-11-21 リップル セラピューティクス コーポレーションズ 二量体ステロイドプロドラッグを含む表面コーティングおよび埋込み可能なデバイス、およびその使用
US12509469B2 (en) 2019-08-07 2025-12-30 Ripple Therapeutics Corporation Compositions and methods for the treatment of pain and dependence disorders
US11389409B2 (en) * 2019-08-30 2022-07-19 Remedy Diagnostics LLC Transdermal device comprising acetaminophen prodrug
CA3176134A1 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
CN113332588B (zh) * 2021-05-26 2023-05-09 四川大学 用于口腔黏膜给药的尖端载药可溶性微针贴片及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2999102A (en) * 1959-10-14 1961-09-05 Thomae Gmbh Dr K Bis-(steroid-21)-dicarboxylic acid esters
US3147183A (en) * 1962-04-16 1964-09-01 Boehringer Sohn Ingelheim Bis-(steroid-21)-dicarboxylic acid esters
FR2576213B1 (fr) * 1985-01-21 1989-02-24 Cortial Nouveau procede d'obtention de formes pharmaceutiques a liberation prolongee
US5028431A (en) * 1987-10-29 1991-07-02 Hercon Laboratories Corporation Article for the delivery to animal tissue of a pharmacologically active agent
TW225536B (cg-RX-API-DMAC7.html) * 1990-08-23 1994-06-21 Ciba Geigy Ag
US5681964A (en) * 1990-10-23 1997-10-28 University Of Kentucky Research Foundation Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents
EP0635019B1 (en) * 1992-04-06 1999-05-26 Biosite Diagnostics Inc. Opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
US5552162A (en) * 1993-02-09 1996-09-03 Arch Development Corporation Method for improvement of scar size and appearance
US6051576A (en) * 1994-01-28 2000-04-18 University Of Kentucky Research Foundation Means to achieve sustained release of synergistic drugs by conjugation
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
US5840731A (en) * 1995-08-02 1998-11-24 Virginia Commonwealth University Pain-alleviating drug composition and method for alleviating pain
DE19607395C2 (de) * 1996-02-28 2002-11-21 Lohmann Therapie Syst Lts Salze aus einem kationischen narkotischen Analgetikum mit einem anionischen nichtnarkotischen Analgetikum, Verfahren zu deren Herstellung und die diese Salze enthaltenden pharmazeutischen Präparate
WO2001013957A2 (en) * 1999-08-24 2001-03-01 Cellgate, Inc. Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
FR2803849B1 (fr) * 2000-01-19 2002-04-19 Centre Nat Rech Scient Molecules chimeres formees de psoralene et de retinoide, leur procede de preparation, et leurs applications au traitement de pathologies de l'hyperproliferation cellulaire et notamment du psoriasis
US6306842B1 (en) * 2000-06-02 2001-10-23 Medinox, Inc. Protected forms of a combination of pharmacologically active agents and uses therefor
US20030118528A1 (en) * 2001-11-19 2003-06-26 Walters Kenneth A. Topical delivery of codrugs
WO2003061626A1 (en) * 2002-01-18 2003-07-31 Control Delivery Systems, Inc. Polymeric gel system for the controlled delivery of codrugs

Similar Documents

Publication Publication Date Title
JP2005518354A (ja) コドラッグを含有する医薬組成物
JP5105697B2 (ja) コドラッグのコントロールデリバリ用ポリマー性ゲルシステム
JP5628467B2 (ja) 生体分解性徐放性ドラッグデリバリーシステム
US20040180036A1 (en) Salts of codrugs and uses related thereto
EP2123274B1 (en) Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same
TW413637B (en) Preparation for percutaneous absorption
ES2549924T3 (es) Análogos de ácido araquidónico y métodos para tratamiento analgésico usando el mismo
PT1962817E (pt) Administração transdérmica de uma forma de sal de meptazinol
JP2014520817A (ja) カンナビノイド受容体結合剤、組成物および方法
US20230128252A1 (en) Pharmaceutical compositions
JPWO2006118173A1 (ja) 経皮吸収製剤
JP2005513050A (ja) 尿生殖路疾患の治療
TW200526272A (en) Suspension delivery system for the sustained and controlled local release of pharmaceuticals
WO2005009480A2 (en) Implants containing codrugs
JP2001270826A (ja) 皮膚疾患治療・予防用外用剤
JP6566707B2 (ja) 経皮唾液腺投与用の唾液分泌促進剤
JP3568881B2 (ja) 皮膚疾患治療用外用剤
ES2356563T3 (es) Administración transdérmica de meptazinol.
WO2019008472A1 (en) PHARMACEUTICAL COMPOSITIONS OF LIGNOCAINE HCL
JP3538367B2 (ja) 皮膚組織障害治療・予防・改善用外用剤
JP2001089371A (ja) ニトロイミダゾール系化合物を含むアトピー性皮膚炎治療用の外用剤
CN1842321B (zh) 生物蚀解性缓释递药系统
JP2001288082A (ja) 乾癬治療・予防用外用剤
HK1174895B (en) Arachidonic acid analogs and methods for analgesic treatment using same